Oestrogens for preventing recurrent urinary tract infection in postmenopausal women

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2008, Pages

  Perrotta, Carla ^a   Aznar, M ^b   Mejia, R ^b   Albert, X ^b   Ng, C W ^b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ESTRADIOL; ESTRIOL; ESTROGEN; MEDROXYPROGESTERONE ACETATE; PLACEBO;

AUTHOR; BLEEDING; BREAST TENDERNESS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COCHRANE LIBRARY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CREAM; DATA ANALYSIS; DATA EXTRACTION; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EMBASE; FOLLOW UP; HEART INFARCTION; HUMAN; INTERVENTION STUDY; LACTOBACILLUS; LANGUAGE; MEDLINE; MENSTRUAL CYCLE; METHODOLOGY; METRORRHAGIA; MODEL; OUTCOME ASSESSMENT; PH; POSTMENOPAUSE; QUALITY CONTROL; RECURRENT INFECTION; REGISTER; REVIEW; RISK FACTOR; SPOTTING; STATISTICAL ANALYSIS; TREATMENT DURATION; URINARY TRACT INFECTION; VAGINA BLEEDING; VAGINA DISCHARGE; VAGINA PESSARY; VAGINAL BURNING SENSATION; VAGINAL PRURITUS;

EID: 44949197835     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005131.pub2     Document Type: Review

References (33)

1. Brown 2001 {published data only} Brown JS, Vittinghoff E, Kanaya AM, Agarwal SK, Hulley S, Foxman B. Urinary tract infections in postmenopausal women: effect of hormone therapy and risk factors. Obstetrics & Gynecology 2001;98(6):1045-52. [MEDLINE: 11755552].
2. Cardozo 1998 {published data only} Cardozo L, Benness C, Abbott D. Low dose oestrogen prophylaxis for recurrent urinary tract infections in elderly women. British Journal of Obstetrics & Gynaecology 1998;105(4):403-7. [MEDLINE: 9609266].
3. Eriksen 1999 {published data only} *Eriksen B. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. American Journal of Obstetrics & Gynecology 1999;180(5):1072-9. [MEDLINE: 10329858].
4. Kirkengen 1992 {published data only} Kirkengen AL, Andersen P, Gjersoe E, Johannessen GR, Johnsen N, Bodd E. Oestriol in the prophylactic treatment of recurrent urinary tract infections in postmenopausal women. Scandinavian Journal of Primary Health Care 1992;10(2):139-42. [MEDLINE: 1641524].
5. Kjaergaard 1990 {published data only} Kjaergaard B, Walter S, Knudsen A, Johansen B, Barlebo H. Treatment with low-dose vaginal oestradiol in post menopausal women. A double-blind controlled investigation [Behandling med lavdosis vaginal ostradiol hos postmenopausale kvinder]. Ugeskr Laeger 1990;152(10):658-9.
6. Ouslander 2001 {published data only} Ouslander JG, Greendale GA, Uman G, Lee C, Paul W, Schnelle J. Effects of oral estrogen and progestin on the lower urinary tract among female nursing home residents. Journal of the American Geriatric Society 2001;49(6):803-7. [MEDLINE: 11454122].
7. Raz 1993 {published data only} Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. New England Journal of Medicine 1993;329(11):753-56. [MEDLINE: 8350884].
8. Raz 2003 {published data only} Raz R, Colodner R, Rohana Y, Battino S, Rottensterich E, Wasser I, et al.Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women. Clinical Infectious Diseases 2003;36(11):1362-8. [MEDLINE: 12766829].
9. Xu 2001 {published data only} Xu R, Wu Y, Hu Y. Prevention and treatment of recurrent urinary system infection with estrogen cream in postmenopausal women. Chung-Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics & Gynecology] 2001;36(9):531-3. [MEDLINE: 11769665].
10. Ayton 1996 Ayton RA, Darling GM, Murkies AL, Farrell EA, Weisberg E, Selinus I, et al.A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy. British Journal of Obstetrics&Gynaecology 1996;103(4):351-8. [MEDLINE: 8605133].
11. Brandberg 1987 Brandberg A, Mellstrom D, Samsioe G. Low dose oral estriol treatment in elderly women with urogenital infections. Acta Obstetricia et Gynecologica Scandinavica - Supplement 1987;140:33-8. [MEDLINE: 3475935].
12. Chompootaweep 1998 Chompootaweep S, Nunthapisud P, Trivijitsilp P, Sentrakul P, Dusitsin N. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study. Clinical Pharmacology & Therapeutics 1998;64(2):204-10. [MEDLINE: 9728901].
13. Henriksson 1996 Henriksson L, Stjernquist M, Boquist L, Cedergren I, Selinus I. A one-yearmulticenter study of efficacy and safety of a continuous, lowdose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging. American Journal of Obstetrics & Gynecology 1996;174(1 Pt 1):85-92. [MEDLINE: 8572039].
14. Marx 2004 Marx P, Schade G, Wilbourn S, Blank S, Moyer D, Nett R. Low-dose (0.3 mg) synthetic conjugated estrogens A is effective for managing atrophic vaginitis. Maturitas 2004;47(1):47-54. [MEDLINE: 14706765].
15. Molander 1990 *Molander U, Milsom I, Ekelund P, Mellstrom D, Eriksson O. Effect of oral oestriol on vaginal flora and cytology and urogenital symptoms in the post-menopause. Maturitas 1990;12(2): 113-20. [MEDLINE: 2255263].
16. Notelovitz 1995 Notelovitz M. Estrogen therapy in the management of problems associated with urogenital ageing: a simple diagnostic test and the effect of the route of hormone administration. Maturitas 1995;22Suppl:S31-3. [MEDLINE: 8775774].
17. Orlander 1992 Orlander JD, Jick SS, Dean AD, Jick H. Urinary tract infections and estrogen use in older women. Journal of the American Geriatric Society 1992;40(8):817-20. [MEDLINE: 1634725].
18. Albert 2004 Albert X, Huertas I, Pereiró I, Sanfélix J, Gosalbes V, Perrotta C. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database of Systematic Reviews 2004, Issue 3.Art. No.: CD001209. DOI: 10.1002/14651858.CD001209.pub2.
19. Brown 1999 Brown JS, Grady D, Ouslander JG, Herzog AR, Varner RE, Posner SF. Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group. Obstetrics&Gynecology 1999;94(1):66-70. [MEDLINE: 10389720].
20. Dickersin 1994 Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994;309(6964):1286- 91. [MEDLINE: 7718048].
21. Foxman 2000 Foxman B, Barlow R, D'Arcy H, Guillespie B, Sobel JD. Urinary tract infection: self reported incidence and associated costs. Annals of Epidemiology 2000;10(8):509-15. [MEDLINE: 11118930].
22. Foxman 2001 Foxman B, Somsel P, Tallman P, Gillespie B, Raz R, Colodner R, et al.Urinary tract infection among women aged 40 to 65: Behavioral and sexual risk factors. Journal of Clinical Epidemiology 2001;54(7):710-18. [MEDLINE: 11438412].
23. Higgins 2003 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency inmeta-analyses. BMJ 2003;327(7414):557- 60. [MEDLINE: 12958120].
24. Hu 2004 Hu KK, Boyko EJ, Scholes D, Normand E, Chen CL, Grafton J, et al.Risk factors for urinary tract infections in postmenopausal women. Archives of Internal Medicine 2004;164(9):989-93. [MEDLINE: 15136308].
25. Iosif 1981 Iosif CS, Batra S, Ek A, Astedt B. Estrogen receptors in the human female lower urinary tract. American Journal of Obstetrics & Gynecology 1981;141(7):817-20. [MEDLINE: 7198384].
26. Jepson 2004 Jepson RG, Mihaljevic L, Craig J. Cranberries for preventing urinary tract infections. Cochrane Database of Systematic Reviews 2004, Issue 2.Art. No.: CD001321. DOI: 10.1002/14651858.CD001321. pub3.
27. Lefebvre 1996 Lefebvre C, McDonald S. Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE. Fourth International Cochrane Colloquium; 1996 Oct 20-24; Adelaide (Australia). 1996.
28. Master List 2007 United States Cochrane Center. Master list of journals being searched. http://apps1.jhsph.edu/cochrane/masterlist.asp (accessed May 2007).
29. Moehrer 2004 Moehrer B, Hextall A, Jackson S. Oestrogens for urinary incontinence in women. Cochrane Database of Systematic Reviews 2004, Issue 2.Art. No.: CD001405. DOI:10.1002/14651858.CD001405.
30. Raz 2000 Raz R, Gennesin Y, Wasser J, Stoler Z, Rosenfeld S, Rottensterich E, et al.Recurrent urinary tract infections in postmenopausal women. Clinical Infectious Diseases 2000;30(1):152-6. [MEDLINE: 10619744].
31. Raz 2001 Raz R. Hormone replacement therapy or prophylaxis in postmenopausal women with recurrent urinary tract infection. Journal of Infectious Diseases 2001;183 Suppl(1):74-6. [MEDLINE: 11171020].
32. Robinson 2003 Robinson D, Cardozo LD. The role of estrogens in female lower urinary tract dysfunction. Urology 2003;62(4 Suppl 1):45-51. [MEDLINE: 14550837].
33. Suckling 2006 Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database of Systematic Reviews 2006, Issue 4.Art. No.: CD001500. DOI: 10.1002/14651858.CD001500. pub2.